Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking

Completed · Phase 2

Conditions studied: Alcohol Dependence

In brief

The purpose of this study is to determine whether naltrexone (an opiate blocking agent approved for the treatment of alcohol dependence), ondansetron a serotonin 3 antagonist medication approved to treat nausea) or their combination are effective in the reduction of alcohol craving and drinking compared to placebo.

Key facts

Study ID
NCT00183222
Run by
Medical University of South Carolina
People needed
160
Starts
2005-05-01
Expected to finish
2005-12-01
Last updated by the study team
2010-05-05

Who can join

Age: 21 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.